CAMBRIDGE, MA -- Researchers at MIT and Stanford University have developed a new way to stimulate the immune system to attack tumor cells, using a strategy that could make cancer immunotherapy work ...

Recombinant glycoproteins produced by mammalian cell lines are currently being developed as therapeutics for a spectrum of diseases. Chinese hamster ovary (CHO) cells are widely used for this purpose.

Some of the most common types of cancer could be successfully treated using a new form of immunotherapy, suggests new research. American scientists showed that using new molecules that block an immune ...